Ambalal Sarabhai Enterprises
AMBALALSANSE

Ambalal Sarabhai Enterprises

₹45.36-2.38 (4.99%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
45.36
Today’s high
48.00
52 week low
30.15
52 week high
49.98
Open price
46.50
Previous close
47.74
Live volume
86,066
Lower circuit
43.10
Upper circuit
47.62

Fundamentals

Market Cap
₹365Cr
ROE
11.24%
P/E Ratio(TTM)
26.92
EPS(TTM)
1.77
P/B Ratio
2.31
Dividend Yield
0.00%
Industry P/E
37.23
Book Value
20.66
Debt to Equity
0.36
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹45.59
-33.05%
Profit (Cr)
₹3.98
-38.77%
-200255075
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)-6%
3Y CAGR+6%
Profit growthValue
1Y (TTM)-52%
3Y CAGR+16%

About

Ambalal Sarabhai Enterprises Limited is a diversified company with core operations in the pharmaceuticals and electronics manufacturing sectors, supported by its subsidiaries and joint ventures. Its focused subsidiaries have recorded significant progress in key areas including Active Pharmaceutical Ingredients manufacturing, Molecular Diagnostics, and niche Effervescent products. The group maintains a clear emphasis on disease-based solutions, leveraging its robust technological capabilities to drive future growth in both healthcare and electronics. Its joint venture, Vovantis, operates a USFDA-approved manufacturing plant in Ranoli, with an increased focus on products for the USA and European markets. Another key subsidiary, Synbiotics, is a USFDA inspected company that manufactures an antifungal active ingredient, Amphotericin B, for an expanding global market. Furthermore, its Asence subsidiary specializes in supplying quality pharmaceutical preparations to international markets, with over 100 products registered worldwide.;
CEO/MD
Mohal K Sarabhai
Founded in
1978
NSE symbol
AMBALALSA

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹4,978.20
+58.20 (1.18%)
L
    H
    22,514.2930.625.36
    ₹2,560.80
    +31.10 (1.23%)
    L
      H
      19,234.0028.375.36
      ₹7,415.50
      -91.50 (1.22%)
      L
        H
        18,760.75110.621.5
        Natco PharmaNATCOPHARM
        ₹882.40
        +4.90 (0.56%)
        L
          H
          15,721.3713.731.7
          2026
          12
          Aug
          Quarterly Result
          Release date
          21
          May
          Quarterly & Annual Result
          Release date
          12
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          11
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks